Abounding with figures and graphs that support key data in the text, the Third Edition contains 7 new chapters on topics including: the genomics of acute myocardial infarction; the use of CRP, myeloperoxidase, N-tyrosine, and other disease markers; new arterial inflammatory markers; the enhancement of microcirculatory perfusion in the coronary bed; the impact of diabetes and metabolic syndrome on the development of ACS; cardiogenic shock and Killip Class III; the use of pluripotent stem cells; BNP and proBNP

Audience:

With detailed contributions from 45 renowned international authorities, this Third Edition stands alone as the most comprehensive, contemporary view of the biology, physiology, and management of acute coronary syndromes (ACS)-offering 32 chapters that span the state-of-the science in the field and provide intriguing discussions on CRP and other disease markers, microcirculation, stem cell therapy, and the development of specialized centers for ACS treatment.